415 related articles for article (PubMed ID: 33155329)
1. Levofloxacin based non-rifampicin anti-tuberculous therapy: An effective alternative in renal transplant recipients in resource limited setting.
Gupta KL; Bagai S; Kumar H; Nayak S; Muthu V; Kumar V; Rathi M; Kohli HS; Sharma A; Ramachandran R
Nephrology (Carlton); 2021 Feb; 26(2):178-184. PubMed ID: 33155329
[TBL] [Abstract][Full Text] [Related]
2. A 10-year experience of tuberculosis in solid-organ transplant recipients.
Ulubay G; Kupeli E; Duvenci Birben O; Seyfettin EP; Dogrul MI; Ozsancak Ugurlu A; Oner Eyuboglu F; Haberal M
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():214-8. PubMed ID: 25894157
[TBL] [Abstract][Full Text] [Related]
3. Tuberculosis in Egyptian kidney transplant recipients: study of clinical course and outcome.
el-Agroudy AE; Refaie AF; Moussa OM; Ghoneim MA
J Nephrol; 2003; 16(3):404-11. PubMed ID: 12832742
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of levofloxacin versus rifampicin in tuberculous meningitis: an open-label randomized controlled trial.
Kalita J; Misra UK; Prasad S; Bhoi SK
J Antimicrob Chemother; 2014 Aug; 69(8):2246-51. PubMed ID: 24752957
[TBL] [Abstract][Full Text] [Related]
5. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis in renal transplant recipients: rifampicin sparing treatment protocol.
Vachharajani TJ; Oza UG; Phadke AG; Kirpalani AL
Int Urol Nephrol; 2002; 34(4):551-3. PubMed ID: 14577503
[TBL] [Abstract][Full Text] [Related]
7. Clinical features and outcomes of tuberculosis in solid organ transplant recipients.
Bodro M; Sabé N; Santín M; Cruzado JM; Lladó L; González-Costello J; Carratalà J
Transplant Proc; 2012 Nov; 44(9):2686-9. PubMed ID: 23146494
[TBL] [Abstract][Full Text] [Related]
8. Incidence, Outcomes, and Long-term Immune Response to Tuberculosis in Organ Transplant Recipients.
Natori Y; Ferreira VH; Nellimarla S; Husain S; Rotstein C; Humar A; Kumar D
Transplantation; 2019 Jan; 103(1):210-215. PubMed ID: 29944616
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of additional levofloxacin in tuberculous meningitis: A randomized controlled pilot study.
Kalita J; Bhoi SK; Betai S; Misra UK
Tuberculosis (Edinb); 2016 May; 98():1-6. PubMed ID: 27156611
[TBL] [Abstract][Full Text] [Related]
10. Kidney transplantation in patients on anti-tubercular therapy: A single centre observational study.
Prasad P; Bagai S; Prasad V; Grover R; Chhabra G; Khullar D
Transpl Infect Dis; 2024 Jun; 26(3):e14242. PubMed ID: 38269612
[TBL] [Abstract][Full Text] [Related]
11. Tuberculosis After Renal Transplant.
Barbouch S; Hajji M; Helal I; Ounissi M; Bacha MM; Ben Hamida F; Abderrahim E; Ben Abdallah T
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):200-203. PubMed ID: 28260468
[TBL] [Abstract][Full Text] [Related]
12. Tuberculous hepatitis in renal transplant recipients following alemtuzumab induction therapy.
Bosch W; Poowanawittayakom N; Chaikriangkrai K; Mendez J; Hellinger WC; Gonwa TA; Krishna M; Pungpapong S
Transpl Infect Dis; 2013 Feb; 15(1):E33-9. PubMed ID: 23278987
[TBL] [Abstract][Full Text] [Related]
13. Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial.
Heemskerk D; Day J; Chau TT; Dung NH; Yen NT; Bang ND; Merson L; Olliaro P; Pouplin T; Caws M; Wolbers M; Farrar J
Trials; 2011 Feb; 12():25. PubMed ID: 21288325
[TBL] [Abstract][Full Text] [Related]
14. Tuberculosis in renal transplant recipients: Our decade long experience with an opportunistic invader.
Eswarappa M; H J GD; John MM; Chennabasappa GK; Siddaiah GM
Indian J Tuberc; 2020 Jan; 67(1):73-78. PubMed ID: 32192621
[TBL] [Abstract][Full Text] [Related]
15. The high incidence of tuberculosis among renal transplant recipients in India.
Sakhuja V; Jha V; Varma PP; Joshi K; Chugh KS
Transplantation; 1996 Jan; 61(2):211-5. PubMed ID: 8600625
[TBL] [Abstract][Full Text] [Related]
16. Impact of type of calcineurin inhibitor on post-transplant tuberculosis: Single-center study from India.
Agarwal SK; Bhowmik D; Mahajan S; Bagchi S
Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27775825
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of tuberculosis in hemodialysis and renal transplant patients.
Vachharajani T; Abreo K; Phadke A; Oza U; Kirpalani A
Am J Nephrol; 2000; 20(4):273-7. PubMed ID: 10970979
[TBL] [Abstract][Full Text] [Related]
18. Acute cellular rejection with coexisting tuberculous interstitial nephritis in renal allograft.
Padmanabhan A; Gadgil NM; Chandrakar S; Kumavat P
Saudi J Kidney Dis Transpl; 2018; 29(1):214-216. PubMed ID: 29456234
[No Abstract] [Full Text] [Related]
19. Tacrolimus as a risk factor for tuberculosis and outcome of treatment with rifampicin in solid organ transplant recipients.
Ha YE; Joo EJ; Park SY; Wi YM; Kang CI; Chung DR; Joh JW; Lee SK; Song JH; Peck KR
Transpl Infect Dis; 2012 Dec; 14(6):626-34. PubMed ID: 22372581
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and outcome of tuberculosis in solid organ transplant recipients.
Hsu MS; Wang JL; Ko WJ; Lee PH; Chou NK; Wang SS; Chu SH; Chang SC
Am J Med Sci; 2007 Aug; 334(2):106-10. PubMed ID: 17700199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
